UK Prime Mnister Boris Johnson cancelled his visit to India, amid the ongoing crisis in the country over the new strain of coronavirus. Johnson spoke to Prime Minister Modi on Tuesday morning,
Bharat Biotech Chairman Krishna Ella said on Monday that the company does not deserve the backlash it is receiving in the light of the India’s drugs regulator granting its coronavirus vaccine Covaxin
The seventh round of meeting of the farmers’ organisation with the government at Vigyan Bhawan on Monday remained inconclusive as the farmers were adamant about withdrawal of the three farm laws. Two
Preying on the toxic mix of a pandemic and unemployment, Chinese-run fintech apps worked with impunity to provide quick loans at exorbitant interest and harassed defaulters leading to five deaths … reports Asian
Independent cyber security researcher Rajshekhar Rajaharia claimed that the data was being sold on the Dark Web for an undisclosed amount via cryptocurrency Bitcoin….reports Asian Lite Newsdesk Independent cyber security researcher Rajshekhar
Reliance Industries Limited (RIL), through its subsidiary Reliance Jio Infocomm Limited (RJIL), in a petition mentioned to be filed in the Punjab and Haryana High Court on Monday, has sought the urgent
On December 31, 2020, the UNGA plenary adopted the resolution by a recorded vote of 130 in favour to nine against, with 25 abstentions…reports Sumi Khan Bangladesh Foreign Minister Foreign Minister AK
With reports emerging about Team India’s reluctance to play the fourth and final Test of the ongoing series against Australia in Brisbane due to harsher bio-security protocols, members of the Queensland government
The India women’s hockey team on Sunday left for Argentina where they are scheduled to play eight matches between January 17 to 31. The Indian team is scheduled to play two matches
Bharat Biotech on Saturday announced successful recruitment of 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for phase-III clinical trial of its coronavirus vaccine ‘Covaxin’ across multiple sites